AI assistant
Sending…
XAAR PLC — Share Issue/Capital Change 2018
Jan 5, 2018
4768_rns_2018-01-05_17be89da-23ea-43e0-b7cf-7aed3eda2a35.html
Share Issue/Capital Change
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 0333B
Xaar PLC
05 January 2018
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
(Note: Italicised terms have the same meaning as given in the Listing Rules.)
Date: 5 January 2018
| Name of applicant: | Xaar plc | |||
| Name of scheme: | 1. Xaar plc SAYE Sharesave scheme 1997 2. Xaar plc 2004 share option plan 3. Xaar plc 1997 share option scheme 4. Xaar Technology 1997 unapproved share option scheme 5. Xaar 2007 Long Term Incentive Plan 6. Xaar plc 2007 Sharesave plan |
|||
| Period of return: | From: | 01/07/2017 | To: | 31/12/2017 |
| Balance of unallotted securities under scheme(s) from previous return: | 1. 280,057 2. 313,500 3. 120,000 4. 85,000 5. 172,682 6. 132,990 |
|||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 1. - 2. - 3. - 4. - 5. - 6. - |
|||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 1. - 2. (22,500) 3. - 4. - 5. (8,026) 6. (132,990) |
|||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 1. 280,057 2. 291,000 3. 120,000 4. 85,000 5. 164,656 6. Nil |
|||
| Name of contact: | Lily Liu |
| Telephone number of contact: | +44 (0) 1223 423 663 |
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRBIGDBDDGBGIS
More from XAAR PLC
Director's Dealing
2026
May 6
Annual Report (ESEF)
2026
May 5
Annual Report
2026
May 5
Regulatory Filings
2026
May 5
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 1
Earnings Release
2026
Mar 24
Investor Presentation
2026
Mar 23
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Jan 14